ATNM logo

Actinium Pharmaceuticals, Inc. (ATNM)

Profile

Full Name

Actinium Pharmaceuticals, Inc.

Ticker

NYSEAmerican: ATNM

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 27, 2012

Indexes

Not included

Website

https://www.actiniumpharma.com

Employees

31

Key Details

Price

$1.59(-4.22%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(-100.00% YoY)

Annual EPS

-$1.27(30.69% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.59
    ATNM price is $1.59

    30-Day Relative Volume

    0.77
    ATNM 30-day relative volume is 0.77

    Price Performance

    Price Most Recent Change

    -4.22%
    ATNM price was down -4.22% on Dec 18, 2025

    Price YTD Change

    +26.19%
    ATNM price is up +26.19% since January 1st

    Price 1-Year Change

    +41.96%
    ATNM price is up +41.96% year-on-year

    Price 3-Year Change

    -84.41%
    ATNM price is down -84.41% over the past 3 years

    Price Range

    Price All-Time High

    $450.00
    ATNM price is currently -99.65% below its historical high of $450.00

    Price 3-Year Low

    $1.03
    ATNM price is currently +54.52% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $49.60M
    ATNM market cap is $49.60 million

    Market Cap 3-Year Change

    -80.92%
    ATNM market cap is down -80.92% over the past 3 years

    Market Cap All-Time High

    $366.12M
    ATNM market cap is currently -86.45% below its historical high of $366.12 million

    Market Cap Sector Percentile

    32.91%
    ATNM market cap is higher than 32.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    ATNM shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +22.42%
    ATNM shares outstanding is up +22.42% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.21
    ATNM beta is 1.21

    200-day SMA

    $1.52
    ATNM price is currently +4.84% above its 200-day simple moving average

    50-day SMA

    $1.43
    ATNM price is currently +10.82% above its 50-day simple moving average

    14-Day RSI

    59.39
    ATNM 14-day relative strength index is 59.39

    Volume

    0.77
    ATNM 30-day relative volume is 0.77

    ATR

    $0.10
    ATNM average true range is $0.10

    10-day Historical Volatility

    69.57%
    ATNM 10-day historical volatility is 69.57%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ATNM annual revenue is $0.00

    Revenue Analysts Estimate

    $93.33K
    ATNM annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -100%
    ATNM annual revenue is down -100% year-on-year

    Revenue Sector Percentile

    28.57%
    ATNM annual revenue is higher than 28.57% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    ATNM annual earnings per share is -$1.27

    EPS Analysts Estimate

    -$1.08
    ATNM annual earnings per share is currently -17.76% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +30.69%
    ATNM annual earnings per share is up +30.69% year-on-year

    EPS Sector Percentile

    49.83%
    ATNM annual earnings per share is higher than 49.83% of companies in Healthcare sector

    Profit

    Gross Profit

    -$811.00K
    ATNM annual gross profit is -$811.00 thousand

    Gross Margin

    -
    ATNM annual gross profit margin value is unknown

    Operating Profit

    -$42.12M
    ATNM annual operating income is -$42.12 million

    Operating Margin

    -
    ATNM annual operating profit margin value is unknown

    Net Income

    -$38.24M
    ATNM annual net profit is -$38.24 million

    Net Margin

    -
    ATNM annual net profit margin value is unknown

    Expenses

    Total Expenses

    $42.12M
    ATNM annual total expenses is $42.12 million

    Operating Expenses

    $42.12M
    ATNM annual total operating expenses is $42.12 million

    Cost Of Goods Sold

    $811.00K
    ATNM annual cost of goods sold is $811.00 thousand

    Selling, General & Administrative Expenses

    $12.08M
    ATNM annual SG&A is $12.08 million

    Depreciation & Amortization

    $811.00K
    ATNM annual D&A is $811.00 thousand

    Interest Expense

    $0.00
    ATNM annual interest expense is $0.00

    Income Tax

    $0.00
    ATNM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$42.12M
    ATNM annual earnings before interest & taxes is -$42.12 million

    EBITDA

    -$41.31M
    ATNM annual EBITDA is -$41.31 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $76.90M
    ATNM annual total assets is $76.90 million

    Non Current Assets

    $2.39M
    ATNM annual long term assets is $2.39 million

    Current Assets

    $74.51M
    ATNM annual total current assets is $74.51 million

    Cash and Cash Equivalents

    $72.90M
    ATNM annual cash & cash equivalents is $72.90 million

    Accounts Receivable

    -
    ATNM annual accounts receivable value is unknown

    Inventory

    $0.00
    ATNM annual inventory is $0.00

    Liabilities

    Total Liabilities

    $44.14M
    ATNM annual total liabilities is $44.14 million

    Long Term Liabilities

    $35.99M
    ATNM annual total long term liabilities is $35.99 million

    Current Liabilities

    $8.15M
    ATNM annual current liabilities is $8.15 million

    Accounts Payable

    $7.57M
    ATNM annual accounts payable is $7.57 million

    Debt

    Total Debt

    $1.57M
    ATNM annual total debt is $1.57 million

    Total Debt 1-Year Change

    -25.56%
    ATNM annual total debt is down -25.56% year-on-year

    Long Term Debt

    $993.00K
    ATNM annual long term debt is $993.00 thousand

    Short Term Debt

    $580.00K
    ATNM annual short term debt is $580.00 thousand

    Equity & Capital

    Shareholders Equity

    $32.76M
    ATNM annual stockholders equity is $32.76 million

    Book Value

    $32.76M
    ATNM annual book value is $32.76 million

    Retained Earnings

    -$375.83M
    ATNM annual retained earnings is -$375.83 million

    Working Capital

    $66.36M
    ATNM annual working capital is $66.36 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$33.07M
    ATNM annual cash from operations is -$33.07 million

    Cash From Operations 1-Year Change

    +30.13%
    ATNM annual cash from operations is up +30.13% year-on-year

    Cash From Investing

    -$11.00K
    ATNM annual cash from investing is -$11.00 thousand

    Cash From Investing 1-Year Change

    +92.81%
    ATNM annual cash from investing is up +92.81% year-on-year

    Cash From Financing

    $29.32M
    ATNM annual cash from financing is $29.32 million

    Cash From Financing 1-Year Change

    +97.18%
    ATNM annual cash from financing is up +97.18% year-on-year

    CAPEX

    CAPEX

    $11.00K
    ATNM annual capital expenditures is $11.00 thousand

    CAPEX 1-Year Change

    -92.81%
    ATNM annual capital expenditures is down -92.81% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$33.08M
    ATNM annual free cash flow is -$33.08 million

    Free Cash Flow 1-Year Change

    +30.33%
    ATNM annual free cash flow is up +30.33% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    ATNM annual gross profit margin value is unknown

    Operating Margin

    -
    ATNM annual operating profit margin value is unknown

    Net Margin

    -
    ATNM annual net profit margin value is unknown

    ROA & ROE

    ROA

    -48.30%
    ATNM annual return on assets is -48.30%

    ROE

    -110.63%
    ATNM annual return on equity is -110.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ATNM price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ATNM price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.60
    ATNM price to book ratio is 3.60

    PB Ratio Sector Percentile

    67.06%
    ATNM price to book ratio is higher than 67.06% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    551.13
    ATNM price to sales ratio is 551.13

    PS Ratio Sector Percentile

    95.57%
    ATNM price to sales ratio is higher than 95.57% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    -$2.65M
    ATNM enterprise value is -$2.65 million

    Enterprise Value Sector Percentile

    8.11%
    ATNM enterprise value is higher than 8.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.07
    ATNM EV/EBITDA is 0.07

    EV/EBITDA Sector Percentile

    63.4%
    ATNM EV/EBITDA is higher than 63.4% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    9.14
    ATNM annual current ratio is 9.14

    Quick Ratio

    9.14
    ATNM annual quick ratio is 9.14

    Leverage

    Debt To Equity

    0.05
    ATNM annual debt to equity ratio is 0.05

    Interest Coverage Ratio

    -
    ATNM annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ATNM piotroski f-score value is unknown

    Altman Z-Score

    -6.94
    ATNM altman z-score is -6.94

    Analyst ratings

    Recent major analysts updates

    Jun 24, 25 HC Wainwright & Co.
    Buy
    May 12, 25 HC Wainwright & Co.
    Buy
    Apr 28, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Mar 27, 25 HC Wainwright & Co.
    Buy
    Mar 25, 25 HC Wainwright & Co.
    Buy
    Mar 20, 25 HC Wainwright & Co.
    Buy
    Mar 18, 25 HC Wainwright & Co.
    Buy
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Nov 19, 24 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with ATNM included

    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Biotech Companies
    Best performing stocks YTD
    • What is the ticker symbol for Actinium Pharmaceuticals, Inc.?
    • Does Actinium Pharmaceuticals, Inc. pay dividends?
    • What sector is Actinium Pharmaceuticals, Inc. in?
    • What industry is Actinium Pharmaceuticals, Inc. in?
    • What country is Actinium Pharmaceuticals, Inc. based in?
    • When did Actinium Pharmaceuticals, Inc. go public?
    • Is Actinium Pharmaceuticals, Inc. in the S&P 500?
    • Is Actinium Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Actinium Pharmaceuticals, Inc. in the Dow Jones?
    • When was Actinium Pharmaceuticals, Inc.'s last earnings report?
    • When does Actinium Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Actinium Pharmaceuticals, Inc.?

    The ticker symbol for Actinium Pharmaceuticals, Inc. is NYSEAmerican:ATNM

    Does Actinium Pharmaceuticals, Inc. pay dividends?

    No, Actinium Pharmaceuticals, Inc. does not pay dividends

    What sector is Actinium Pharmaceuticals, Inc. in?

    Actinium Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Actinium Pharmaceuticals, Inc. in?

    Actinium Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Actinium Pharmaceuticals, Inc. based in?

    Actinium Pharmaceuticals, Inc. is headquartered in United States

    When did Actinium Pharmaceuticals, Inc. go public?

    Actinium Pharmaceuticals, Inc.'s initial public offering (IPO) was on December 27, 2012

    Is Actinium Pharmaceuticals, Inc. in the S&P 500?

    No, Actinium Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Actinium Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Actinium Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Actinium Pharmaceuticals, Inc. in the Dow Jones?

    No, Actinium Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Actinium Pharmaceuticals, Inc.'s last earnings report?

    Actinium Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2025

    When does Actinium Pharmaceuticals, Inc. report earnings?

    The date for Actinium Pharmaceuticals, Inc.'s next earnings report has not been announced yet
    On this page